Wong Alvin F — SEC Form 4 filings
SEC reporting owner CIK 1868855. 2 Form 4 filings on record with FilingPulse; latest filed 2024-02-14.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2024-01-10 to 2024-02-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 280 shares, $1,053 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
- Largest priced transaction: sale of 280 shares @ $3.76 ($1,053) in PUMA BIOTECHNOLOGY, INC., filed 2024-01-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | Chief Scientific Officer | 2 | — | 1 leg · 280 sh · $1,053 | 2 |
Form 4 filings — Wong Alvin F
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-02-14 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/award (A): 43,307 @ $0 · Grant/award (A): 59,946 (derivative) @ $0 | EDGAR |
| 2024-01-10 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale (S): 280 @ $3.76 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-10 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1868855 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →